Emir M Muzurović (Emir Muzurovic, Emir Muzurović)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Systematic Review

Cardiovascular Risk Factors

Top Venues

Journal of cardiovascular pharmacology and therapeutics

Medicina (Kaunas, Lithuania)

Pharmacological reviews

The international journal of lower extremity wounds

This page only lists publications with an associated author ORCID identifier.

Publications

Michail Kokkorakis, Emir M Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A Hill, Dimitri P Mikhailidis, Christos S Mantzoros
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological reviews 76 (3) (2024)
Emir M Muzurović, Marija Maćešić, Sreten Kavarić
Liver Fibrosis and Atherosclerosis, a Consequence of Metabolic Dysfunction-Do They Share a Similar Pathophysiological Background? Angiology (2024)
Michail Kokkorakis, Emir M Muzurović, Špela Volčanšek, Marlene Chakhtoura, Michael A Hill, Dimitri P Mikhailidis, Christos S Mantzoros
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological reviews 76 (3) (2024)
Ioana-Cristina Bica, Roxana Adriana Stoica, Teodor Salmen, Andrej Janez, Špela Volčanšek, Djordje Popovic, Emir M Muzurović, Manfredi Rizzo, Anca Mihaela Pantea Stoian
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Vesna Bokan, Emir M Muzurović, Sonja Nejkov, Manfredi Rizzo, Nikoloas Papanas
Quality of Life in People with Diabetes Mellitus and Unilateral Transtibial Amputation - Aspects of Using the Berg Balance Scale. The international journal of lower extremity wounds (2023)
Ioana-Cristina Bica, Roxana Adriana Stoica, Teodor Salmen, Andrej Janez, Špela Volčanšek, Djordje Popovic, Emir M Muzurović, Manfredi Rizzo, Anca Mihaela Pantea Stoian
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Ioana-Cristina Bica, Roxana Adriana Stoica, Teodor Salmen, Andrej Janez, Špela Volčanšek, Djordje Popovic, Emir M Muzurović, Manfredi Rizzo, Anca Mihaela Pantea Stoian
The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials. Medicina (Kaunas, Lithuania) 59 (6) (2023)
Teodor Salmen, Liviu-Ionut Serbanoiu, Ioana-Cristina Bica, Cristian Serafinceanu, Emir M Muzurović, Andrej Janez, Stefan Sebastian Busnatu, Maciej Banach, Ali Abbas Rizvi, Manfredi Rizzo, Anca Mihaela Pantea Stoian
A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy-A Systematic Review and Meta-Analysis. International journal of molecular sciences 24 (11) (2023)
Rosaria Vincenza Giglio, Emir M Muzurović, Angelo Maria Patti, Peter P Toth, Manyoo A Agarwal, Wael Almahmeed, Aleksandra Klisic, Marcello Ciaccio, Manfredi Rizzo
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm? Journal of cardiovascular pharmacology and therapeutics 28 (2023)
Emir M Muzurović, Špela Volčanšek, Karin Zibar Tomšić, Andrej Janež, Dimitri P Mikhailidis, Manfredi Rizzo, Christos S Mantzoros
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Emir M Muzurović, Špela Volčanšek, Karin Zibar Tomšić, Andrej Janež, Dimitri P Mikhailidis, Manfredi Rizzo, Christos S Mantzoros
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence. Journal of cardiovascular pharmacology and therapeutics 27 (2022)
Emir M Muzurović, Sanja Medenica, Milovan Kalezić, Siniša Pavlović
Primary hyperparathyroidism associated with acquired long QT interval and ventricular tachycardia. Endocrinology, diabetes & metabolism case reports 2021 (2021)
Emir M Muzurović, Snežana Vujošević, Dimitri P Mikhailidis
Can We Decrease Epicardial and Pericardial Fat in Patients With Diabetes? Journal of cardiovascular pharmacology and therapeutics 26 (5) (2021)
Emir M Muzurović, Dimitri P Mikhailidis
Diabetes Mellitus and Noncardiac Atherosclerotic Vascular Disease-Pathogenesis and Pharmacological Treatment Options. Journal of cardiovascular pharmacology and therapeutics 26 (1) (2020)